Biogen Inc. buy Royal Bank of Canada
Start price
31.07.23
/
50%
€245.60
Target price
31.07.24
€339.11
Performance (%)
-19.97%
End price
01.08.24
€196.55
Summary
This prediction ended on 01.08.24 with a price of €196.55. The prediction for Biogen Inc. disappointed with a performance of -19.97%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 4.174% | 4.174% | -46.662% |
| iShares Core DAX® | 0.101% | -1.369% | 29.083% |
| iShares Nasdaq 100 | 0.526% | 1.372% | 3.279% |
| iShares Nikkei 225® | -2.812% | -0.280% | -1.761% |
| iShares S&P 500 | 1.027% | 1.097% | 4.775% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $379.00 to $374.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten